ATA125383A - Verfahren zur herstellung von neuen benzoazacycloalkyl-spiro-imidazolidinen - Google Patents
Verfahren zur herstellung von neuen benzoazacycloalkyl-spiro-imidazolidinenInfo
- Publication number
- ATA125383A ATA125383A AT0125383A AT125383A ATA125383A AT A125383 A ATA125383 A AT A125383A AT 0125383 A AT0125383 A AT 0125383A AT 125383 A AT125383 A AT 125383A AT A125383 A ATA125383 A AT A125383A
- Authority
- AT
- Austria
- Prior art keywords
- benzoazacycloalkyl
- imidazolidines
- spiro
- producing new
- producing
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8207203A FR2525603A1 (fr) | 1982-04-27 | 1982-04-27 | Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATA125383A true ATA125383A (de) | 1986-05-15 |
Family
ID=9273425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0125383A ATA125383A (de) | 1982-04-27 | 1983-04-08 | Verfahren zur herstellung von neuen benzoazacycloalkyl-spiro-imidazolidinen |
Country Status (22)
| Country | Link |
|---|---|
| JP (1) | JPS5910584A (cg-RX-API-DMAC7.html) |
| KR (1) | KR840004428A (cg-RX-API-DMAC7.html) |
| AT (1) | ATA125383A (cg-RX-API-DMAC7.html) |
| AU (1) | AU1395383A (cg-RX-API-DMAC7.html) |
| BE (1) | BE896572A (cg-RX-API-DMAC7.html) |
| DD (1) | DD209833A5 (cg-RX-API-DMAC7.html) |
| DE (1) | DE3315106A1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK183583A (cg-RX-API-DMAC7.html) |
| ES (1) | ES521895A0 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2525603A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB2133401B (cg-RX-API-DMAC7.html) |
| GR (1) | GR78481B (cg-RX-API-DMAC7.html) |
| IL (1) | IL68497A0 (cg-RX-API-DMAC7.html) |
| IT (1) | IT1167123B (cg-RX-API-DMAC7.html) |
| LU (1) | LU84770A1 (cg-RX-API-DMAC7.html) |
| MA (1) | MA19783A1 (cg-RX-API-DMAC7.html) |
| NL (1) | NL8301476A (cg-RX-API-DMAC7.html) |
| NO (1) | NO831473L (cg-RX-API-DMAC7.html) |
| OA (1) | OA07412A (cg-RX-API-DMAC7.html) |
| PT (1) | PT76595B (cg-RX-API-DMAC7.html) |
| SE (1) | SE8302347L (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA832927B (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4927831A (en) * | 1988-10-20 | 1990-05-22 | American Home Products | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| AU617541B2 (en) * | 1988-10-20 | 1991-11-28 | Wyeth | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
| US6953787B2 (en) | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
| SI2332921T1 (sl) | 2003-06-17 | 2016-06-30 | Arena Pharmaceuticals, Inc. | 8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazapin hidroklorid |
| EA016558B1 (ru) | 2003-06-17 | 2012-05-30 | Арена Фармасьютикалз, Инк. | Производные бензазепина, используемые для лечения заболеваний, ассоциированных с 5-ht-рецептором |
| US8168624B2 (en) | 2004-12-21 | 2012-05-01 | Arena Pharmaceuticals, Inc. | Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride |
| EP2111859A1 (en) | 2004-12-23 | 2009-10-28 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulator compositions and methods of use |
| JP5199997B2 (ja) | 2006-04-03 | 2013-05-15 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ８−クロロ−１−メチル−２，３，４，５−テトラヒドロ−１ｈ−３−ベンズアゼピンおよびこれに関連する中間体を調製するためのプロセス |
| WO2008070111A2 (en) | 2006-12-05 | 2008-06-12 | Arena Pharmaceuticals, Inc. | Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof |
| CN102015591B (zh) | 2008-03-04 | 2014-01-29 | 艾尼纳制药公司 | 制备与5-ht2c激动剂(r)-8-氯-1-甲基-2，3，4，5-四氢-1h-3-苯并氮杂卓相关的中间体的方法 |
| WO2010148207A2 (en) | 2009-06-18 | 2010-12-23 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-ht2c receptor agonists |
| WO2011153206A1 (en) | 2010-06-02 | 2011-12-08 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-ht2c receptor agonists |
| CN103189360A (zh) | 2010-09-01 | 2013-07-03 | 艾尼纳制药公司 | 5-ht2c激动剂的非吸湿性盐 |
| KR20180094131A (ko) | 2010-09-01 | 2018-08-22 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 신장 손상을 갖는 개체에 대한 로카세린의 투여 |
| SG188362A1 (en) | 2010-09-01 | 2013-04-30 | Arena Pharm Inc | Modified-release dosage forms of 5-ht2c agonists useful for weight management |
| SG10201506870PA (en) | 2010-09-01 | 2015-10-29 | Arena Pharm Inc | Salts of lorcaserin with optically active acids |
| WO2014058441A1 (en) | 2012-10-09 | 2014-04-17 | Arena Pharmaceuticals, Inc. | Method of weight management |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4209630A (en) * | 1976-10-18 | 1980-06-24 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
| US4235911A (en) * | 1979-06-13 | 1980-11-25 | Pfizer Inc. | Hydantoin derivatives |
-
1982
- 1982-04-27 FR FR8207203A patent/FR2525603A1/fr active Granted
-
1983
- 1983-04-08 AT AT0125383A patent/ATA125383A/de not_active IP Right Cessation
- 1983-04-25 LU LU84770A patent/LU84770A1/fr unknown
- 1983-04-25 DD DD83250187A patent/DD209833A5/de unknown
- 1983-04-26 ZA ZA832927A patent/ZA832927B/xx unknown
- 1983-04-26 BE BE0/210633A patent/BE896572A/fr not_active IP Right Cessation
- 1983-04-26 IT IT48155/83A patent/IT1167123B/it active
- 1983-04-26 NO NO831473A patent/NO831473L/no unknown
- 1983-04-26 DK DK183583A patent/DK183583A/da not_active Application Discontinuation
- 1983-04-26 PT PT76595A patent/PT76595B/pt unknown
- 1983-04-26 IL IL68497A patent/IL68497A0/xx unknown
- 1983-04-26 JP JP58073687A patent/JPS5910584A/ja active Pending
- 1983-04-26 SE SE8302347A patent/SE8302347L/xx not_active Application Discontinuation
- 1983-04-26 NL NL8301476A patent/NL8301476A/nl not_active Application Discontinuation
- 1983-04-26 GR GR71214A patent/GR78481B/el unknown
- 1983-04-26 AU AU13953/83A patent/AU1395383A/en not_active Abandoned
- 1983-04-26 KR KR1019830001753A patent/KR840004428A/ko not_active Withdrawn
- 1983-04-27 DE DE19833315106 patent/DE3315106A1/de not_active Withdrawn
- 1983-04-27 OA OA57984A patent/OA07412A/xx unknown
- 1983-04-27 ES ES521895A patent/ES521895A0/es active Granted
- 1983-04-27 GB GB08311508A patent/GB2133401B/en not_active Expired
- 1983-04-27 MA MA20003A patent/MA19783A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB8311508D0 (en) | 1983-06-02 |
| DE3315106A1 (de) | 1983-11-03 |
| GB2133401A (en) | 1984-07-25 |
| PT76595A (fr) | 1983-05-01 |
| SE8302347D0 (sv) | 1983-04-26 |
| FR2525603A1 (fr) | 1983-10-28 |
| FR2525603B1 (cg-RX-API-DMAC7.html) | 1984-09-14 |
| DK183583D0 (da) | 1983-04-26 |
| NL8301476A (nl) | 1983-11-16 |
| SE8302347L (sv) | 1983-10-28 |
| GB2133401B (en) | 1985-10-23 |
| NO831473L (no) | 1983-10-28 |
| ZA832927B (en) | 1984-06-27 |
| ES8405796A1 (es) | 1984-06-16 |
| OA07412A (fr) | 1984-11-30 |
| IT8348155A0 (it) | 1983-04-26 |
| MA19783A1 (fr) | 1983-12-31 |
| IL68497A0 (en) | 1983-07-31 |
| DK183583A (da) | 1983-10-28 |
| LU84770A1 (fr) | 1984-11-28 |
| KR840004428A (ko) | 1984-10-15 |
| JPS5910584A (ja) | 1984-01-20 |
| GR78481B (cg-RX-API-DMAC7.html) | 1984-09-27 |
| BE896572A (fr) | 1983-10-26 |
| ES521895A0 (es) | 1984-06-16 |
| DD209833A5 (de) | 1984-05-23 |
| PT76595B (fr) | 1986-01-21 |
| AU1395383A (en) | 1983-11-03 |
| IT1167123B (it) | 1987-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT377524B (de) | Verfahren zur herstellung von neuen anthracyclinglycosiden | |
| AT382612B (de) | Verfahren zur herstellung von neuen arylcyclobutylalkylaminen | |
| AT382638B (de) | Verfahren zur herstellung von neuen trehaloselipiden | |
| AT384017B (de) | Verfahren zur herstellung von neuen hydroxyaminoestern | |
| ATA206483A (de) | Verfahren zur herstellung von neuen mitosanderivaten | |
| ATA125383A (de) | Verfahren zur herstellung von neuen benzoazacycloalkyl-spiro-imidazolidinen | |
| AT386199B (de) | Verfahren zur herstellung von neuen 2-piperazinopyrimidinen | |
| AT385035B (de) | Verfahren zur herstellung von neuen ergolinderivaten | |
| AT386828B (de) | Verfahren zur herstellung von neuen acylaminomitosanen | |
| AT380683B (de) | Verfahren zur herstellung von neuen diaminophenolaethern | |
| AT376679B (de) | Verfahren zur herstellung von neuen bisindolalkaloiden | |
| ATA279784A (de) | Verfahren zur herstellung von neuen 2-aminomethyl-2-penem-verbindungen | |
| AT383125B (de) | Verfahren zur herstellung von neuen mutterkornalkaloiden | |
| AT387385B (de) | Verfahren zur herstellung von neuen substituierten 1-pyridyloxy-3-indolylalkylamino-2-propanolen | |
| AT384214B (de) | Verfahren zur herstellung von neuen mercaptoacylcarnitinen | |
| AT385509B (de) | Verfahren zur herstellung von neuen mitosanverbindungen | |
| AT373231B (de) | Verfahren zur herstellung von neuen alkoxyalkanoyl-carnitinhydrohalogeniden | |
| AT382874B (de) | Verfahren zur herstellung von neuen mutterkornalkaloiden | |
| AT381939B (de) | Verfahren zur herstellung von neuen azaspiroalkandionen | |
| ATA91083A (de) | Verfahren zur herstellung von neuen dicarbamaten | |
| AT378776B (de) | Verfahren zur herstellung von neuen anthracyclinglycosiden | |
| ATA354581A (de) | Verfahren zur herstellung von neuen 11-hydroxy-13 -oxa-postaglandinderivaten | |
| AT377980B (de) | Verfahren zur herstellung von neuen diastereomeren | |
| ATA67481A (de) | Verfahren zur herstellung von neuen androstancarbothioaten | |
| ATA46086A (de) | Verfahren zur herstellung von neuen 2-thiacephemderivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1J | Withdrawal paragraph 166 lit. 6 | ||
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |